Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Federal Circuit Affirms Dismissal of Declaratory Judgment Counterclaims in Trusopt/Cosopt Case
Oct 10, 2008 10:45 AM
- Federal Circuit Affirms Dismissal of Prasco's Declaratory Judgment Suit Against Medicis
Oct 07, 2008 12:52 PM
- Another Seal of Approval For Micromet
Aug 19, 2008 10:52 AM
- American On Sale
Jul 25, 2008 11:50 AM
- Periodicals Wrap-Up for Friday, May 23rd
May 23, 2008 09:27 AM
- Analyst Comments: Stoneridge, Array Pharma, Finisar, Infinity Pharma, CombinatoRx, Ness Tech, Human Genome
May 06, 2008 04:53 PM
- District Court Dismisses Impax's Declaratory Judgment Complaint in ANDA Case Against Medicis
Apr 25, 2008 01:06 AM
- AstraZeneca is Waiting to be Found by Investors
Mar 22, 2008 04:47 PM
- Big Pharma?s Expected Revenues
Jul 11, 2007 09:11 PM
- Oxygen Breakthrough Interview Now Available on MN1.com and Invitrogen Launches New Engineered Stem Cell Line
Jun 18, 2007 09:30 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
MEDI
|
Compare to S&P
|
| YTD |
-0.01 %
|
65.61 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 32.00 %
|
|
EPS Growth in Last Year: 186.96 %
|
|
Sales Growth in Last Quarter: 8.72 %
|
|
Sales Growth in Last Quarter: 15.42 %
|
|
|
